サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1411497

脳疾患モダリティ＆ソフトウェア市場：製品タイプ、患者タイプ、適応症別-2024～2030年の世界予測

Brain Disease Modalities & Software Market by Product (Brain Analysis Software, Brain Imaging Modalities), Patient Type (Adults, Infants, Pediatrics), Indication - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
脳疾患モダリティ＆ソフトウェア市場：製品タイプ、患者タイプ、適応症別-2024～2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脳疾患モダリティ＆ソフトウェア市場規模は2023年に151億8,000万米ドルと推計され、2024年には161億1,000万米ドルに達し、CAGR 5.33%で2030年には218億4,000万米ドルに達すると予測されます。

脳疾患モダリティ＆ソフトウェアの世界市場

主な市場の統計
基準年[2023］ 151億8,000万米ドル
予測年[2024] 161億1,000万米ドル
予測年 [2030] 218億4,000万米ドル
CAGR（%） 5.33%
Brain Disease Modalities &Software Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは脳疾患モダリティ＆ソフトウェア市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、脳疾患モダリティ＆ソフトウェア市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-脳疾患モダリティ＆ソフトウェア市場の市場規模および予測は？

2-脳疾患モダリティ＆ソフトウェア市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-脳疾患モダリティ＆ソフトウェア市場における技術動向と規制の枠組みは？

4-脳疾患モダリティ＆ソフトウェア市場における主要ベンダーの市場シェアは？

5-脳疾患モダリティ＆ソフトウェア市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 脳障害の蔓延と診断に対する意識の高まり
      • 脳疾患管理におけるデジタルソリューションの使用を奨励する政府の取り組み
      • 脳疾患検査における神経画像診断法の採用の増加
    • 抑制要因
      • 試験装置にソフトウェアテクノロジーを統合する際の複雑さ
    • 機会
      • AIとMLをベースとした先進的な脳疾患ソフトウェアのイントロダクション
      • 脳疾患治療センターの拡充・設立への投資
    • 課題
      • データプライバシーとセキュリティ侵害に関連する懸念
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 脳疾患モダリティ＆ソフトウェア市場：製品別

  • 脳分析ソフトウェア
  • 脳画像診断法
    • CT装置
    • MRI装置
    • PET装置
    • PET-CT
    • PET-MRI

第7章 脳疾患モダリティ＆ソフトウェア市場患者タイプ別

  • 大人
  • 幼児
  • 小児科

第8章 脳疾患モダリティ＆ソフトウェア市場適応症別

  • 脳の病気
    • 脳腫瘍
    • 中枢神経系がん
    • 特発性てんかん
    • 虚血性脳卒中
  • 神経変性疾患
    • アルツハイマー病
    • 運動神経の病気
    • 多発性硬化症
    • パーキンソン病

第9章 南北アメリカの脳疾患モダリティ＆ソフトウェア市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の脳疾患モダリティ＆ソフトウェア市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの脳疾患モダリティ＆ソフトウェア市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Aspect Imaging Ltd.
    • Brainomix Limited
    • Canon Medical Systems Corporation
    • Carestream Health, Inc.
    • Esaote S.p.A.
    • Fujifilm Holdings Corporation
    • General Electric Company,
    • Imaging Biometrics LLC
    • International Business Machines Corporation
    • IXICO plc.
    • Koninklijke Philips N.V.,
    • MIM Software, Inc.
    • Quantib B.V.
    • ScienceSoft USA Corporation
    • Siemens Healthineers AG
    • VUNO Inc.
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. BRAIN DISEASE MODALITIES & SOFTWARE MARKET RESEARCH PROCESS
  • FIGURE 2. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BRAIN DISEASE MODALITIES & SOFTWARE MARKET DYNAMICS
  • FIGURE 7. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 10. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 12. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. BRAIN DISEASE MODALITIES & SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 9. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MRI DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PET DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PET-CT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PET-MRI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 21. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IDIOPATHIC EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 27. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MOTOR NEURON DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 281. BRAIN DISEASE MODALITIES & SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 282. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 283. BRAIN DISEASE MODALITIES & SOFTWARE MARKET LICENSE & PRICING
目次
Product Code: MRR-5C6F41F5AFA8

[194 Pages Report] The Brain Disease Modalities & Software Market size was estimated at USD 15.18 billion in 2023 and expected to reach USD 16.11 billion in 2024, at a CAGR 5.33% to reach USD 21.84 billion by 2030.

Global Brain Disease Modalities & Software Market

KEY MARKET STATISTICS
Base Year [2023] USD 15.18 billion
Estimated Year [2024] USD 16.11 billion
Forecast Year [2030] USD 21.84 billion
CAGR (%) 5.33%
Brain Disease Modalities & Software Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Brain Disease Modalities & Software Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Brain Disease Modalities & Software Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Brain Disease Modalities & Software Market, highlighting leading vendors and their innovative profiles. These include Aspect Imaging Ltd., Brainomix Limited, Canon Medical Systems Corporation, Carestream Health, Inc., Esaote S.p.A., Fujifilm Holdings Corporation, General Electric Company,, Imaging Biometrics LLC, International Business Machines Corporation, IXICO plc., Koninklijke Philips N.V.,, MIM Software, Inc., Quantib B.V., ScienceSoft USA Corporation, Siemens Healthineers AG, and VUNO Inc..

Market Segmentation & Coverage

This research report categorizes the Brain Disease Modalities & Software Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Brain Analysis Software
    • Brain Imaging Modalities
      • CT Devices
      • MRI Devices
      • PET Devices
      • PET-CT
      • PET-MRI
  • Patient Type
    • Adults
    • Infants
    • Pediatrics
  • Indication
    • Brain Diseases
      • Brain Cancer
      • Central Nervous System Cancer
      • Idiopathic Epilepsy
      • Ischemic Stroke
    • Neurodegenerative Diseases
      • Alzheimer's Disease
      • Motor Neuron Disease
      • Multiple Sclerosis
      • Parkinson's Disease
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Brain Disease Modalities & Software Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Brain Disease Modalities & Software Market?

3. What are the technology trends and regulatory frameworks in the Brain Disease Modalities & Software Market?

4. What is the market share of the leading vendors in the Brain Disease Modalities & Software Market?

5. Which modes and strategic moves are suitable for entering the Brain Disease Modalities & Software Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Brain Disease Modalities & Software Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of brain disorders and increasing awareness regarding seeking diagnosis
      • 5.1.1.2. Government initiatives encouraging the use of digital solutions in brain disease management
      • 5.1.1.3. Increasing adoption of neuroimaging modalities for brain disease testing
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities of integrating software technologies in testing equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of advanced brain disease software based on AI and ML
      • 5.1.3.2. Investments in the expansion and establishment of brain disease treatment centers
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with data privacy and security breaches
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Brain Disease Modalities & Software Market, by Product

  • 6.1. Introduction
  • 6.2. Brain Analysis Software
  • 6.3. Brain Imaging Modalities
    • 6.4.1. CT Devices
    • 6.4.2. MRI Devices
    • 6.4.3. PET Devices
    • 6.4.4. PET-CT
    • 6.4.5. PET-MRI

7. Brain Disease Modalities & Software Market, by Patient Type

  • 7.1. Introduction
  • 7.2. Adults
  • 7.3. Infants
  • 7.4. Pediatrics

8. Brain Disease Modalities & Software Market, by Indication

  • 8.1. Introduction
  • 8.2. Brain Diseases
    • 8.3.1. Brain Cancer
    • 8.3.2. Central Nervous System Cancer
    • 8.3.3. Idiopathic Epilepsy
    • 8.3.4. Ischemic Stroke
  • 8.3. Neurodegenerative Diseases
    • 8.4.1. Alzheimer's Disease
    • 8.4.2. Motor Neuron Disease
    • 8.4.3. Multiple Sclerosis
    • 8.4.4. Parkinson's Disease

9. Americas Brain Disease Modalities & Software Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Brain Disease Modalities & Software Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Brain Disease Modalities & Software Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Aspect Imaging Ltd.
    • 13.1.2. Brainomix Limited
    • 13.1.3. Canon Medical Systems Corporation
    • 13.1.4. Carestream Health, Inc.
    • 13.1.5. Esaote S.p.A.
    • 13.1.6. Fujifilm Holdings Corporation
    • 13.1.7. General Electric Company,
    • 13.1.8. Imaging Biometrics LLC
    • 13.1.9. International Business Machines Corporation
    • 13.1.10. IXICO plc.
    • 13.1.11. Koninklijke Philips N.V.,
    • 13.1.12. MIM Software, Inc.
    • 13.1.13. Quantib B.V.
    • 13.1.14. ScienceSoft USA Corporation
    • 13.1.15. Siemens Healthineers AG
    • 13.1.16. VUNO Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing